Cargando…
Permeability across a novel microfluidic blood-tumor barrier model
BACKGROUND: The lack of translatable in vitro blood-tumor barrier (BTB) models creates challenges in the development of drugs to treat tumors of the CNS and our understanding of how the vascular changes at the BBB in the presence of a tumor. METHODS: In this study, we characterize a novel microfluid...
Autores principales: | Terrell-Hall, Tori B., Ammer, Amanda G., Griffith, Jessica I. G., Lockman, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260004/ https://www.ncbi.nlm.nih.gov/pubmed/28114946 http://dx.doi.org/10.1186/s12987-017-0050-9 |
Ejemplares similares
-
Trastuzumab distribution in an in-vivo and in-vitro model of brain metastases of breast cancer
por: Terrell-Hall, Tori B., et al.
Publicado: (2017) -
A Quasi-Physiological Microfluidic Blood-Brain Barrier Model for Brain Permeability Studies
por: Noorani, Behnam, et al.
Publicado: (2021) -
Microfluidic organotypic device to test intestinal mucosal barrier permeability ex vivo
por: Cherwin, Amanda E., et al.
Publicado: (2023) -
Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity
por: Mulac, Dennis, et al.
Publicado: (2012) -
Permeability of Epithelial/Endothelial Barriers in Transwells and Microfluidic Bilayer Devices
por: Frost, Timothy S., et al.
Publicado: (2019)